Literature DB >> 25446396

Physical exercise prior and during treatment reduces sub-chronic doxorubicin-induced mitochondrial toxicity and oxidative stress.

Inês Marques-Aleixo1, Estela Santos-Alves2, Diogo Mariani3, David Rizo-Roca4, Ana I Padrão5, Sílvia Rocha-Rodrigues3, Ginés Viscor4, J Ramon Torrella4, Rita Ferreira5, Paulo J Oliveira6, José Magalhães3, António Ascensão3.   

Abstract

Doxorubicin (DOX) is an anti-cancer agent whose clinical usage results in a cumulative and dose-dependent cardiotoxicity. We have previously shown that exercise performed prior to DOX treatment reduces the resulting cardiac(mito) toxicity. We sought to determine the effects on cardiac mitochondrial toxicity of two distinct chronic exercise models (endurance treadmill training-TM and voluntary free-wheel activity-FW) when used prior and during DOX treatment. Male-young Sprague-Dawley rats were divided into six groups (n=6 per group): SAL+SED (saline sedentary), SAL+TM (12-weeks TM), SAL+FW (12-weeks FW), DOX+SED (7-weeks of chronic DOX treatment 2mg/kg per week), DOX+TM and DOX+FW. DOX administration started 5weeks after the beginning of the exercise protocol. Heart mitochondrial ultrastructural alterations, mitochondrial function (oxygen consumption and membrane potential), semi-quantification of oxidative phosphorylation (OXPHOS) proteins and their in-gel activity, as well as proteins involved in mitochondrial oxidative stress (SIRT3, p66shc and UCP2), biogenesis (PGC1α and TFAM), acetylation and markers for oxidative damage (carbonyl groups, MDA,SH, aconitase, Mn-SOD activity) were evaluated. DOX treatment resulted in ultrastructural and functional alterations and decreased OXPHOS. Moreover, DOX decreased complex I activity and content, mitochondrial biogenesis (TFAM), increased acetylation and oxidative stress. TM and FW prevented DOX-induced alteration in OXPHOS, the increase in oxidative stress, the decrease in complex V activity and in complex I activity and content. DOX-induced decreases in TFAM and SIRT3 content were prevented by TM only. Both chronic models of physical exercise performed before and during the course of sub-chronic DOX treatment translated into an improved mitochondrial bioenergetic fitness, which may result in part from the prevention of mitochondrial oxidative stress and damage.
Copyright © 2014 © Elsevier B.V. and Mitochondria Research Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adriamycin; Bioenergetics; Cardioprotection; Exercise; Oxidative damage

Mesh:

Substances:

Year:  2014        PMID: 25446396     DOI: 10.1016/j.mito.2014.10.008

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  23 in total

Review 1.  Curing Cancer, Saving the Heart: A Challenge That Cardioncology Should Not Miss.

Authors:  Daniela Cardinale; Gina Biasillo; Carlo Maria Cipolla
Journal:  Curr Cardiol Rep       Date:  2016-06       Impact factor: 2.931

2.  VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection.

Authors:  Markus Räsänen; Joni Degerman; Tuuli A Nissinen; Ilkka Miinalainen; Risto Kerkelä; Antti Siltanen; Janne T Backman; Eero Mervaala; Juha J Hulmi; Riikka Kivelä; Kari Alitalo
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-31       Impact factor: 11.205

Review 3.  Exercise Training and Cardiovascular Health in Cancer Patients.

Authors:  Ray W Squires; Adam M Shultz; Joerg Herrmann
Journal:  Curr Oncol Rep       Date:  2018-03-10       Impact factor: 5.075

4.  Rehabilitation and exercise oncology program: translating research into a model of care.

Authors:  M A Dalzell; N Smirnow; W Sateren; A Sintharaphone; M Ibrahim; L Mastroianni; L D Vales Zambrano; S O'Brien
Journal:  Curr Oncol       Date:  2017-06-27       Impact factor: 3.677

Review 5.  Exercise training in cancer related cardiomyopathy.

Authors:  Julian G Westphal; P Christian Schulze
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

6.  Sirtuin-3 (SIRT3) Protein Attenuates Doxorubicin-induced Oxidative Stress and Improves Mitochondrial Respiration in H9c2 Cardiomyocytes.

Authors:  Kyle G Cheung; Laura K Cole; Bo Xiang; Keyun Chen; Xiuli Ma; Yvonne Myal; Grant M Hatch; Qiang Tong; Vernon W Dolinsky
Journal:  J Biol Chem       Date:  2015-03-10       Impact factor: 5.157

7.  Mitochondrial accumulation of doxorubicin in cardiac and diaphragm muscle following exercise preconditioning.

Authors:  Aaron B Morton; Andres Mor Huertas; J Matthew Hinkley; Noriko Ichinoseki-Sekine; Demetra D Christou; Ashley J Smuder
Journal:  Mitochondrion       Date:  2018-02-21       Impact factor: 4.160

Review 8.  Mitochondrial Sirtuins and Doxorubicin-induced Cardiotoxicity.

Authors:  Ling He; Fuxiang Liu; Juxiang Li
Journal:  Cardiovasc Toxicol       Date:  2021-01-12       Impact factor: 3.231

9.  Resistance training improves cardiac function and cardiovascular autonomic control in doxorubicin-induced cardiotoxicity.

Authors:  Larissa Andrade de Sá Feitosa; Jéssica Dos Santos Carvalho; Cácia Oliveira Dantas; Diego Santos de Souza; Carla Maria Lins de Vasconcelos; Rodrigo Miguel-Dos-Santos; Sandra Lauton-Santos; Lucindo José Quíntans-Júnior; Márcio Roberto Viana Santos; Valter Joviniano de Santana-Filho; André Sales Barreto
Journal:  Cardiovasc Toxicol       Date:  2021-01-02       Impact factor: 3.231

10.  An Association Rule Mining Analysis of Lifestyle Behavioral Risk Factors in Cancer Survivors with High Cardiovascular Disease Risk.

Authors:  Su Jung Lee; Kathleen B Cartmell
Journal:  J Pers Med       Date:  2021-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.